UQ researchers have developed a process to capture and tag bacterial contaminants from large sample volumes

Lessening the risk factors associated with glycemic variability in patients within the ICU

Prognostic test to overcome the greatest unmet need in HR+ breast cancer

UQ researchers have identified novel adjuvants to re-sensitise antibiotic resistant bacteria

Endocytosis inhibitor adjuvant therapy enhances the ability of monoclonal antibodies to kill resistant tumour cells

Small molecule inhibitors of haematopoietic prostaglandin D2 synthase for treating asthma and allergic rhinitis

UQ researchers have developed a novel process to incorporate water-insoluble APIs into sol-gel formulations,

Small molecule modulators of human complement C3a protein receptor 1 for treating inflammatory and metabolic diseases.

A novel method of generating large numbers of pure fetal ECFCs from a single human term placenta.